Delivery Order SPE2DP23D0001-SPE2D626F44BC
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain division awarded a delivery order valued at $2,090.49 to the Canadian Commercial Corporation (CCC) on October 16, 2025, for the procurement of Reactive Skin Decontamination Lotion (RSDL). This is a firm fixed-price delivery order with no set-aside designation, reflecting CCC's status as a government-to-government contracting entity rather than a small business concern. The work is scheduled for completion by January 2, 2026, with...
- The U.S. Defense Logistics Agency Medical Supply Chain division awarded a $43,273 delivery order to Canadian Commercial Corporation (CCC) on January 6, 2026, for the procurement of Reactive Skin Decontamination Lotion (RSDL). This firm fixed-price delivery order is scheduled for completion by March 23, 2026, with performance occurring at CCC's headquarters in Ottawa, Ontario, Canada. The contract carries no set-aside designation, consistent with CCC's status as a foreign government entity and...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $2,163.65 delivery order to Canadian Commercial Corporation (CCC) on January 28, 2026, for the procurement of Reactive Skin Decontamination Lotion (RSDL). This delivery order, which represents a child contract under a larger indefinite delivery vehicle, is scheduled for completion by April 13, 2026, with performance to be fulfilled at CCC's headquarters in Ottawa, Ontario. The contract carries firm fixed-price terms with...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $2,090.49 delivery order to Canadian Commercial Corporation (CCC) on October 16, 2025, for the procurement of Reactive Skin Decontamination Lotion (RSDL) with an ultimate completion date of January 2, 2026. This delivery order carries no set-aside designation and will be performed at CCC's headquarters in Ottawa, Ontario, Canada. CCC, a Crown corporation owned by the Government of Canada, serves as a prime contractor to...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $2,163.65 delivery order to the Canadian Commercial Corporation (CCC) on January 28, 2026, for Reactive Skin Decontamination Lotion (RSDL) with an ultimate completion date of April 13, 2026. This firm fixed-price delivery order is being performed at CCC's headquarters in Ottawa, Ontario, Canada. As a Crown corporation owned by the Government of Canada and registered as a foreign government entity in SAM.gov, CCC serves as a...
- The Defense Logistics Agency Medical Supply Chain division awarded a delivery order valued at approximately $4.2K to Canadian Commercial Corporation (CCC) on December 9, 2025, for the procurement of Reactive Skin Decontamination Lotion (RSDL) with an ultimate completion date of February 25, 2026. This firm fixed-price delivery order carries no set-aside designation and will be performed at CCC's headquarters location in Ottawa, Ontario, Canada. CCC, a Crown corporation owned by the Government of...
- The Defense Logistics Agency Medical Supply Chain division awarded a $2,090.49 firm fixed price delivery order to Canadian Commercial Corporation (CCC) on November 16, 2025, for Reactive Skin Decontamination Lotion (RSDL), with ultimate completion scheduled for February 2, 2026. This delivery order carries no set-aside designation, consistent with CCC's status as a foreign government entity and Crown corporation owned by the Government of Canada. The work will be performed at CCC's...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $35,538.33 firm fixed-price delivery order to Canadian Commercial Corporation (CCC) on November 5, 2025, for the procurement of Reactive Skin Decontamination Lotion (RSDL). The work will be performed in Ottawa, Ontario, Canada, with an ultimate completion date of January 23, 2026. This delivery order carries no set-aside designation, consistent with CCC's role as a Crown corporation operating as a government-to-government...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $2,090.49 to Canadian Commercial Corporation (CCC) on November 16, 2025, for Reactive Skin Decontamination Lotion (RSDL). This is a firm fixed-price delivery order with an ultimate completion date of February 2, 2026, with performance occurring at CCC's headquarters in Ottawa, Ontario, Canada. The award carries no set-aside designation, consistent with CCC's status as a foreign government entity and...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $14,633.43 to Canadian Commercial Corporation (CCC) for Reactive Skin Decontamination Lotion (RSDL) with an ultimate completion date of January 23, 2026. This firm fixed-price delivery order, awarded November 5, 2025, represents a child contract executed against a larger indefinite delivery vehicle. CCC, a Crown corporation owned by the Government of Canada, functions as a government-to-government...
- SPE2DP23D0001Indefinite Delivery Contract
- SPE2DP23D0001-SPE2D626F44BCDelivery Order
The U.S. Defense Department's Medical Supply Chain division awarded a delivery order valued at $6,490.95 to Canadian Commercial Corporation (CCC) on February 4, 2026, for Reactive Skin Decontamination Lotion (RSDL). The order, which carries no set-aside designation, is scheduled for completion by April 20, 2026, with performance taking place at CCC's headquarters in Ottawa, Ontario, Canada. RSDL is a critical chemical defense product used by military personnel to neutralize and remove chemical and biological agents from skin, representing an essential component of the Department of Defense's chemical, biological, radiological, and nuclear (CBRN) defense posture. Canadian Commercial Corporation, a Crown corporation of the Government of Canada, serves as a prime contractor facilitating government-to-government procurement relationships between U.S. defense agencies and Canadian manufacturers. CCC has demonstrated substantial contracting capacity across defense logistics, having delivered hundreds of orders valued in the hundreds of millions of dollars across fiscal years 2025-2026 alone, including aircraft components, ammunition, medical supplies, and mechanical assemblies. This delivery order represents one of numerous medical supply procurements CCC has executed through the Defense Logistics Agency's Medical Supply Chain division, with the corporation maintaining active federal contracting status and three major Indefinite Delivery Contracts totaling approximately $57.4 million across Air Force, Naval, and Army programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 2/3/26 |